Mediated intestinal immunity by GALT (Gut Associated Lymphoid Tissue) in inflammatory bowel disease
DOI:
https://doi.org/10.33448/rsd-v13i12.47647Keywords:
GALT; Intestine; Microbiota.Abstract
Gut-associated lymphoid tissue (GALT) plays a fundamental role in the process of pathogen recognition, communication and activation of the immune system. Its response depends on the inflammatory state experienced by the individual and also on intestinal microbial colonization, which can influence homeostasis conditions or even contribute to tolerance and immunological memory processes. However, the role of GALT in inflammatory bowel diseases (IBD) is not yet completely understood. IBD affects the gastrointestinal tract, promoting lack of control of the immune system, which starts attacking cells in the tissue itself, promoting tissue damage. In this sense, the main objective of this narrative review is to understand the role of GALT in IBD; identifying the role of the microbiota within this scenario. To this end, 35 scientific articles were selected, published in Portuguese and English, in the period from 2020 to 2024, in the Scholar, Scielo, Pubmed and Sciencedirect databases. The inflammatory state generated by the pathogenic microbiota can hyperstimulate the GALT, enhancing the emergence or even intensification of intestinal inflammatory diseases. In this sense, the use of prebiotics, probiotics, synbiotics and postbiotics can modulate the intestinal microbiota, promoting a less probiotic environment. inflammatory.
References
Active caldic. (2021). Imunidade e intestino:você conhece a relação? Magistralcaldic.com.br. 2021
https://magistralbr.caldic.com/blog/imunidade-e-intestino-voce-conhece-a-relacao. Acesso em 24/08/24.
Adamczak, A. M., Werblińska, A., Jamka, M., & Walkowiak, J. (2024). Maternal-Foetal/Infant Interactions-Gut Microbiota and Immune Health. Biomedicines. 2024 Feb 22; 12(3), 490. doi: 10.3390/biomedicines12030490. PMID: 38540103; PMCID: PMC10967760.
Aggarwal, N, Kitano, S, Puah, G. R. Y, Kittelmann, S, Hwang, I. Y, & Chang, M. W. (2022). Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chem Rev. 2023 Jan 11;123(1), 31-72.
doi: 10.1021/acs.chemrev.2c00431. Epub 2022 Nov 1. PMID: 36317983; PMCID: PMC9837825.
Bemark, M. et al. (2021). Gut- associated lymphoid tissue: a microbiota-driven hub of B cell. Trends in Immunology, Volume 45, Issue 3, 211 – 22. 1Department of Translational Medicine–Human Immunology, Lund University, J Waldenströms gata 35, Malmö, Sweden 2Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden 3Peter Gorer Department of Immunobiology, King’s College London, Guy’s Hospital Campus, St Thomas’ Street, London SE1 9RT, UK 4https://www.kcl.ac.uk/research/ spencer-group. https://doi.org/10.1016/j.it.2024.01.006.
Didriksen, B. J., Eshleman, E. M. & Alenghat, T. (2024). Epithelial regulation of microbiota-immune cell dynamics. Mucosal Immunology (2024) 17, 303–313; Published: March 08,2024. https://doi.org/10.1016/j.mucimm.2024.02.008.
Chulick, J. B. G., Martinussi, G. O. G., Freita, D. M., Guarana, L. D. Xavier, M. E. D., & Guimareaes, A. C. C. M.. (2023). A influência do microbioma intestinal na saúde humana. Uma revisão da literatura. Brasilian Journal of Health. Curitiba¨(4), 16308-16322, jul/aug, 2023.
Diez-Martin, E, Hernandez-Suarez, L, Muñoz-Villafranca, C, Martin-Souto, L, Astigarraga, E, Ramirez-Garcia, A, & Barreda-Gómez, G. (2024). Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. Int J Mol Sci. 2024 Jun 27; 25(13), 7062. doi: 10.3390/ijms25137062. PMID: 39000169; PMCID: PMC11241012.
Dong, Y, Zhang, K, Wei, J, Ding, Y, Wang, X, Hou, H, Wu, J, Liu, T, Wang ,B, & Cao, H. (2023). Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? Front Immunol. 2023 Apr 14; 14, 1158200.
doi: 10.3389/fimmu.2023.1158200. PMID: 37122756; PMCID: PMC10140337.
Facchin, S.; Bertin, L.; Bonazzi, E.; Lorenzon, G.; De Barba, C.; Barberio, B.; Zingone, F.; Maniero, D.; Scarpa, M.; Ruffolo, C.; et al. (2024). Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. Life 2024,14,559. https://doi.org/ 10.3390/life14050559.
Franca, Greik M., Cruz, G. S. Morais, R. P., Dias, A. K. C. Araujo, M. E. S., Moreira, L. M., & Soares, A. L. F. (2021). O efeito imunomodulador das microbiota intestinal, as consequencias de seu desequilíbrio e a profilaxia probiótica.Revista iberto-Americana de Humaniodades, Ciencia e Educacao – REASE. São Paulo, 7(9), set.2021.
Gebraye, l P, Nicco, C, Al Khodor, S, Bilinski, J, Caselli, E, Comelli, E. M, Egert, M, Giaroni, C, Karpinski, T. M, Loniewski, I, Mulak, A, Reygner, J, Samczuk, P, Serino, M, Sikora, M, Terranegra, A, Ufnal, M, Villeger, R, Pichon, C, Konturek, P, & Edeas, M. (2022). Microbiota medicine: towards clinical revolution. J Transl Med. 2022 Mar 7; 20(1), 111. doi: 10.1186/s12967-022-03296-9. PMID: 35255932; PMCID: PMC8900094.
Iaolin, W, Qianjin, L, Sujie, J, & Ming Z. (2023). immune microenvironment and autoimmunity, International Immunopharmacology, Volume 124, Part A, 2023,110842, ISSN1567-5769,
https://doi.org/10.1016/j.intimp.2023.110842. (https://www.sciencedirect.com/science/article/pii/S1567576923011670).
Ji, J, Jin, W, Liu, SJ, Jiao, Z, & Li, X. (2020). Probiotics, prebiotics, and postbiotics in health and disease. MedComm (2020). 2023 Nov 4; 4(6), e420.
doi: 10.1002/mco2.420. PMID: 37929014; PMCID: PMC10625129.
Laniewski, P, Ilhan, ZE, & Herbst-Kralovetz, MM. (2020). The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020 Apr; 17(4), 232-250. doi: 10.1038/s41585-020-0286-z. Epub 2020 Feb 18. PMID: 32071434; PMCID: PMC9977514.
Lin, S, Mukherjee, S, Li, J, Hou, W, Pan, C, & Liu, J. (2021). Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches. Sci Adv. 2021 May 12;7(20): eabf0677. doi: 10.1126/sciadv.abf0677. Erratum in: Sci Adv. 2022 Feb 11;8(6): eabo0538. doi: 10.1126/sciadv. abo0538. PMID: 33980483; PMCID: PMC8115924.
Lu, X, Shi, Z, Jiang, L, & Zhang, S. (2024). Maternal gut microbiota in the health of mothers and offspring: from the perspective of immunology. Front Immunol. 2024 Mar 13; 15, 1362784. doi: 10.3389/fimmu.2024.1362784. PMID: 38545107; PMCID: PMC10965710.
Marconi, M. A. & Lakatos, E. M. (2015). Metodologia científica: ciência e conhecimento científico, métodos científicos, teoria, hipóteses e variáveis, metodologia jurídica. In: Metodologia científica: ciência e conhecimento científico, métodos científicos, teoria, hipóteses e variáveis, metodologia jurídica. 2015. p. 314-314.
Mörbe, UM, Jørgensen, PB, Fenton, TM, von Burg, N, Riis, LB, Spencer, J, & Agace, WW. (2021). Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 2021 Jul; 14(4), 793-802. doi: 10.1038/s41385-021-00389-4. Epub 2021 Mar 22. PMID: 33753873.
Moretti, Sonia. Schietroma, Ivan. Sberna, Giuseppe. Maggiorella, Maria Teresa, Sernicola,Leonardo. ,. act, & Borsetti,Alessandra. (2023). HIV-1- Host Interaction in Gut – Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities.2023
Moretti, S, Schietroma, I, Sberna, G, Maggiorella, MT, Sernicola, L, Farcomeni, S, Giovanetti, M, Ciccozzi, M, & Borsetti, A. (2023). HIV-1-Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities. Int J Mol Sci. 2023 Jul 30; 24(15), 12193.
doi: 10.3390/ijms241512193. PMID: 37569570; PMCID: PMC10418605.
Popov, J, Caputi, V, Nandeesha, N, Rodriguez, DA, & Pai, N. (2021). Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci. 2021 Oct 21; 22(21), 11365. doi: 10.3390/ijms222111365. PMID: 34768795; PMCID: PMC8584103.
Power, ML, Muletz-Wolz, CR, & Bornbusch, SL. (2024). Microbiome: Mammalian milk microbiomes: sources of diversity, potential functions, and future research directions. Reprod Fertil. 2024 Apr 12; 5(2), e230056. doi: 10.1530/RAF-23-0056. PMID: 38513351; PMCID: PMC11046322.
Quaglio, AEV, Grillo, TG, De Oliveira, ECS, Di Stasi, LC, & Sassaki, LY. (2022). Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022 Aug 14; 28(30), 4053-4060. doi: 10.3748/wjg.v28.i30.4053. PMID: 36157114; PMCID: PMC9403435.
Roy, S, & Dhaneshwar, S. (2023). Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol. 2023 Apr 14;29(14):2078-2100. doi: 10.3748/wjg.v29.i14.2078. Erratum in: World J Gastroenterol. 2023 Sep 21; 29(35), 5178-5179.
doi: 10.3748/wjg.v29.i35.5178. PMID: 37122604; PMCID: PMC10130969.
Shakhpazyan, N, Mikhaleva, L, Bedzhanyan, A, Gioeva, Z, Sadykhov, N, Mikhalev, A, Atiakshin, D, Buchwalow, I, Tiemann, M, & Orekhov, A. (2023). Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets. Biomedicines. 2023 Aug 23; 11(9), 2361. doi: 10.3390/biomedicines11092361. PMID: 37760801; PMCID: PMC10525158.
Singh, P, Al Mohannadi, N, Murugesan, S, Almarzooqi, F, Kabeer, BSA, Marr, AK, Kino, T, Brummaier, T, Terranegra, A, McGready, R, Nosten, F, Chaussabel, D, & Al Khodor, S. (2023). Unveiling the dynamics of the breast milk microbiome: impact of lactation stage and gestational age. J Transl Med. 2023 Nov 6;21(1), 784. doi: 10.1186/s12967-023-04656-9. PMID: 37932773; PMCID: PMC10629158.
Stoeva, M. K., Garcia-So, J., Justice, N., Myers, J., Tyagi, S., Nemchek, M., …& Eid, J. (2021). Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. GUT MICROBES 2021, 13(1), e1907272 (28pages) https://doi.org/10.1080/19490976.2021
Vandenplas, Y, Carnielli, VP, Ksiazyk, J, Luna, MS, Migacheva, N, Mosselmans, JM, Picaud, JC, Possner, M, Singhal, A, & Wabitsch, M. (2020). Factors affecting early-life intestinal microbiota development. Nutrition. 2020 Oct; 78, 110812. doi: 10.1016/j.nut.2020.110812. Epub 2020 Mar 25. PMID: 32464473.
Yan, J. B, Luo, M. M, Chen, Z. Y, & He, B. H. (2020). The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease. J Immunol Res. 2020 Dec 15; 2020:8813558. doi: 10.1155/2020/.
Yao, Q, Li, H, Fan, L, Zhang, Y, Zhao, S, Zheng, N, & Wang, J. (2021). Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease. Foods. 2021 Feb 8; 10(2), 368. doi: 10.3390/foods10020368. PMID: 33567698; PMCID: PMC7915342.
Yutong, W, Qiaolin, Wang, Sujie, J, Qianjin, L, & Ming, Z. (2024). Gut-tropic T cells and extra-intestinal autoimmune diseases. Autoimmunity Reviews ,2024, 103544,ISSN1568-9972,https://doi.org/10.1016/j.autrev.2024.103544.
Zakerska-Banaszak, O, Zuraszek-Szymanska, J, Eder, P, Ladziak, K, Slomsk,i R, & Skrzypczak-Zielinska, M. (2024). The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis. Int J Mol Sci. 2024 Sep 4; 25(17), 9589. doi: 10.3390/ijms25179589. PMID: 39273536; PMCID: PMC11394875.
Zhang, D, Jian, Y. P, Zhang ,Y. N, Li, Y, Gu, L. T, Sun, H. H, Liu, M. D, Zhou, H. L, Wang, Y. S, & Xu, Z. X. (2023). Short-chain fatty acids in diseases. Cell Commun Signal. 2023 Aug 18; 21(1), 212. doi: 10.1186/s12964-023-01219-9. PMID: 37596634; PMCID: PMC10436623.
Zheng, D, Liwinski, T, & Elinav, E. (2020). Interaction between microbiota and immunity in health and disease. Cell Res. 2020 Jun;30(6), 492-506.
doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20. PMID: 32433595; PMCID: PMC7264227.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Márcia Cristina Andrioli Bertoldi; Patrick dos Santos da Silva; Sergio Ricardo de Brito Bello; Camila Tedeschi Pazello; Raquel Simone Maccarini Zarpellon; Amanda Caroline Venturelli; Roxane Wirschum Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
